Harnessing MetAP2 Inhibition
We are applying our proprietary understanding of the MetAP2 pathway to develop treatments for both rare and more prevalent complex metabolic disorders.
LEARN MORE
Addressing Complex Metabolic Disorders
We are committed to significantly improving the health and well-being of people affected by Prader-Willi syndrome, Type 2 diabetes and other metabolic conditions.
LEARN MORELiving Our Purpose
Our team is inspired by patients, their families and caregivers, and we are committed to unlocking the value of MetAP2 inhibition to make a difference in their lives.
LEARN MORE
